← Back to Search

Sentence Training for Aphasia

N/A
Recruiting
Led By Jiyeon Lee, PhD
Research Sponsored by Purdue University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Normal or corrected to normal hearing and vision
Be older than 18 years old
Must not have
Severe apraxia of speech
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline up to 1-week post training or 2-month post treatment
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to improve sentence production and comprehension in people with aphasia using a technique that subtly influences the brain to enhance language skills without the person being fully aware of it. The goal is to create lasting improvements in language abilities by frequently exposing the brain to certain language patterns.

Who is the study for?
This trial is for English-speaking adults who had a stroke in the left hemisphere of their brain at least 6 months ago, causing aphasia. They should have completed high school and have normal or corrected vision and hearing. Participants must struggle with forming sentences but can use some words independently. Those with uncontrolled mental health issues, substance abuse, severe speech apraxia, or other neurological conditions affecting communication cannot join.
What is being tested?
The study is testing a new method to improve sentence formation and understanding in people with aphasia using 'implicit priming'. Researchers will first identify the most effective priming conditions for learning enhancement before developing and evaluating a novel treatment based on these initial findings.
What are the potential side effects?
Since this intervention involves language training exercises rather than medication or invasive procedures, traditional physical side effects are not expected. However, participants may experience fatigue or frustration during the learning process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My hearing and vision are normal, or corrected to be normal.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have severe difficulty speaking clearly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline up to 1-week post training or 2-month post treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline up to 1-week post training or 2-month post treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Comprehension of target sentences in a sentence-to-picture matching task
Production of target sentences on action description pictures
Real-time comprehension of target sentences in a sentence-to-picture matching task
Secondary study objectives
Connected speech production - picture description
Connected speech production - story retell
Production of untrained sentences

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Structural priming trainingExperimental Treatment1 Intervention
Participants will be enrolled in 3 sessions of structural priming training (for experiment 1-3) or up to 15 treatment sessions (for experiment 4). Each session will be about 2 hour long, consisting of a set of tasks, including repeating, making, and remembering various types of sentences. In experiment 1-3, each participant will receive two different experimental priming conditions that are being compared within each session. In experiment 4, participants will receive a structural priming treatment in a single-subject design.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Implicit priming for Aphasia treatment uses subconscious cues to enhance sentence production and comprehension by leveraging the brain's residual language abilities. This method involves repeated exposure to specific linguistic patterns, helping to reactivate and strengthen neural pathways associated with language. This approach is important for Aphasia patients as it offers a non-invasive and potentially more natural way to regain language skills, improving their communication abilities and overall quality of life.
Increasing aphasia treatment intensity in an acute inpatient rehabilitation program: A feasibility study.Evaluation of lexically and nonlexically based reading treatment in a deep dyslexic.

Find a Location

Who is running the clinical trial?

Purdue UniversityLead Sponsor
233 Previous Clinical Trials
71,269 Total Patients Enrolled
Temple UniversityOTHER
316 Previous Clinical Trials
89,203 Total Patients Enrolled
3 Trials studying Aphasia
448 Patients Enrolled for Aphasia
University of California, San DiegoOTHER
1,189 Previous Clinical Trials
1,587,604 Total Patients Enrolled
Jiyeon Lee, PhDPrincipal InvestigatorPurdue University

Media Library

Sentence Production Training Clinical Trial Eligibility Overview. Trial Name: NCT05415501 — N/A
Aphasia Research Study Groups: Structural priming training
Aphasia Clinical Trial 2023: Sentence Production Training Highlights & Side Effects. Trial Name: NCT05415501 — N/A
Sentence Production Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05415501 — N/A
~31 spots leftby May 2026